Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial

BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the ac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurosurgery
Main Authors: Fam, Maged D, Hanley, Daniel, Stadnik, Agnieszka, Zeineddine, Hussein A, Girard, Romuald, Jesselson, Michael, Cao, Ying, Money, Lynn, McBee, Nichol, Bistran-Hall, Amanda J, Mould, W Andrew, Lane, Karen, Camarata, Paul J, Zuccarello, Mario, Awad, Issam A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Research—Human—Clinical Studies
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257031/
https://ncbi.nlm.nih.gov/pubmed/28402516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyx123
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares